Cutaneous malignant melanoma

Clinical trials for Cutaneous malignant melanoma explained in plain language.

Never miss a new study

Get alerted when new Cutaneous malignant melanoma trials appear

Sign up with your email to follow new studies for Cutaneous malignant melanoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet finished but already full! 3 Completed 1

New drug combo shows promise in early cancer trial

Disease control Completed

This early-stage study tests a new drug called WTX-124, given alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. About 150 adults with certain…

Matched conditions: CUTANEOUS MALIGNANT MELANOMA

Phase 1 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC

Cutaneous malignant melanoma

Get alerted when new Cutaneous malignant melanoma trials appear

New drug combo shows promise in early cancer trial